Joseph Michael Fitzgerald - Feb 12, 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP & Group Pres, Cardiology
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Feb 12, 2025
Transactions value $
-$167,011
Form type
4
Date filed
2/14/2025, 05:29 PM
Previous filing
Jan 3, 2025
Next filing
Feb 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +3.46K +2% $0.00 176K Feb 12, 2025 Direct F1
transaction BSX Common Stock Tax liability -$167K -1.58K -0.9% $105.77 175K Feb 12, 2025 Direct
holding BSX Common Stock 4.89K Feb 12, 2025 By Child F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -3.46K -25% $0.00 10.4K Feb 12, 2025 Common Stock 3.46K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.